AITOR PALOMINO FERNANDEZ DE LARREA-rekin lankidetzan egindako argitalpenak (10)

2018

  1. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis

    EMBO Molecular Medicine, Vol. 10, Núm. 8

2016

  1. Axon-to-glia interaction regulates gabaa receptor expression in oligodendrocytes

    Molecular Pharmacology, Vol. 89, Núm. 1, pp. 63-74

  2. Cystine/glutamate antiporter blockage induces myelin degeneration

    GLIA, Vol. 64, Núm. 8, pp. 1381-1395

2014

  1. Novel association of Neuregulin 1 gene with bipolar disorder but not with schizophrenia

    Schizophrenia Research

2013

  1. Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis

    BMC Psychiatry, Vol. 13

  2. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 44, pp. 29-33

2012

  1. Serum IgG antibodies against the NR1 subunit of the NMDA Receptor not detected in schizophrenia

    American Journal of Psychiatry

2010

  1. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics

    International Clinical Psychopharmacology, Vol. 25, Núm. 4, pp. 241-245

2007

  1. Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder

    Schizophrenia Research, Vol. 95, Núm. 1-3, pp. 174-178

2006

  1. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients

    Schizophrenia Research